Summary of Key Points Core Viewpoint - Tianyu Biotechnology Co., Ltd.'s controlling shareholder and actual controller, Luo Weiguo, responded to the inquiry regarding the company's stock trading anomalies, confirming no major asset restructuring or significant transactions are being planned at this time [1]. Group 1: Company Response - As of now, aside from the publicly disclosed issuance of shares to specific targets, there are no ongoing plans for major asset restructuring, share issuance, significant transactions, business restructuring, share buybacks, equity incentives, bankruptcy reorganization, major business cooperation, or the introduction of strategic investors by the controlling shareholder and actual controller [1]. - During the period of abnormal stock trading, the controlling shareholder and actual controller did not engage in buying or selling the company's stock [1].

1、截至目前,除你公司已公开披露的向特定对象发行股票事项外,本人不 存在正在筹划涉及公司的重大资产重组、股份发行、重大交易类事项、业务重组、 股份回购、股权激励、破产重整、重大业务合作、引进战略投资者等重大事项。 关于《天域生物科技股份有限公司 股票交易异常波动的问询函》的回复 天域生物科技股份有限公司: 你公司发来的《天域生物科技股份有限公司股票交易异常波动的问询函》已 收悉。作为天域生物科技股份有限公司控股股东和实际控制人,经自查,现就有 关事项回复如下: (本页无正文,为关于《天域生物科技股份有限公司股票交易异常波动的问 询函》的回复之签署页） 罗卫国 2025 年 09 月 09 日 2、在本次公司股票交易异常波动期间，本人不存在买卖公司股票的情况。 特此回复。 (以下无正文,为本回复之签署页) ...

股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：603717 证券简称：天域生物 公告编号：2025-078 天域生物科技股份有限公司 重要内容提示: 经公司自查，公司目前经营正常，公司市场环境或行业政策未发生重大调整、 生产成本和销售等情况亦未出现大幅波动、内部经营秩序正常。 （二）重大事项情况 一、股票交易异常波动的具体情况 公司股票于 2025 年 09 月 05 日、09 月 08 日、09 月 09 日连续三个交易日内 收盘价格涨幅偏离值累计超过 20%，根据《上海证券交易所交易规则》等有关规 定，属于股票交易异常波动的情形。 二、公司关注并核实的相关情况 1 天域生物科技股份有限公司（以下简称"公司"）股票于 2025 年 09 月 05 日、09 月 08 日、09 月 09 日连续三个交易日内收盘价格涨幅偏离值累 计超过 20%，根据《上海证券交易所交易规则》等有关规定，属于股票 交易异常波动的情形。 公司已于 2025 年 08 月 30 日披露了《2025 年半年度报告》，公 ...

Group 1 - The aquaculture sector increased by 3.66% on September 8, with Tianyu Biological leading the gains [1] - The Shanghai Composite Index closed at 3826.84, up 0.38%, while the Shenzhen Component Index closed at 12666.84, up 0.61% [1] - Key stocks in the aquaculture sector showed significant price increases, with Tianyu Biological rising by 9.99% to a closing price of 8.92 [1] Group 2 - The trading volume and turnover for major aquaculture stocks were notable, with New Hope achieving a turnover of 1.529 billion and Muyuan Foods at 3.188 billion [1] - The net capital flow in the aquaculture sector showed a net outflow of 84.746 million from institutional investors and 189 million from speculative funds, while retail investors had a net inflow of 274 million [2] - Specific stock capital flows indicated that Muyuan Foods had a net inflow of 227 million from institutional investors, while Tianyu Biological experienced a net outflow of 20.72 million from speculative funds [3]

Group 1 - Pork stocks experienced a rapid increase at the beginning of trading on September 8, with Tianyu Biological hitting the daily limit, and Aonong Biological rising over 8% [1] - Other companies in the sector, including Juxing Agriculture, Wens Foodstuffs, and Muyuan Foods, also saw their stock prices rise [1]

Core Insights - Tianyu Biological recently disclosed its main operational data for the pig farming business in August, indicating significant sales and revenue changes [1] Sales Performance - In August, the company sold 26,000 pigs, generating a sales revenue of 29.8423 million yuan, with month-on-month changes of 50.83% in sales volume and 41.89% in revenue [1] - Cumulatively, from January to August 2025, the company sold 247,400 pigs, representing a year-on-year increase of 17.77%, while the total sales revenue reached 362 million yuan, showing a slight year-on-year decline of 0.05% [1] Inventory Status - As of the end of August, the pig inventory stood at 181,000 heads, reflecting a year-on-year increase of 22.29% and a month-on-month increase of 10.49% [1]

Core Points - The company reported significant changes in its pig farming business for August 2025, with a total of 26,000 pigs sold and revenue of 29.84 million yuan, reflecting a month-on-month increase of 50.83% in sales volume and 41.89% in revenue, but a year-on-year decrease of 2.04% in sales volume and a substantial 53.32% drop in revenue [2] - Cumulatively, from January to August 2025, the company sold 247,400 pigs, marking a year-on-year increase of 17.77%, while total revenue for the same period was 362.41 million yuan, showing a slight decline of 0.05% year-on-year [2] - As of the end of August 2025, the company's pig inventory stood at 181,000 pigs, which is a year-on-year increase of 22.29% and a month-on-month increase of 10.49% [2] Summary of Business Data - In August 2025, the company sold 26,000 pigs, generating revenue of 29.84 million yuan, with notable month-on-month growth [2] - Year-to-date sales from January to August 2025 reached 247,400 pigs, with total revenue of 362.41 million yuan [2] - The company's pig inventory at the end of August 2025 was 181,000 pigs, indicating growth in both year-on-year and month-on-month comparisons [2]

Core Viewpoint - The decline in average selling prices of live pigs in August has led to a decrease in sales revenue for several listed companies in the pig farming sector, indicating a challenging market environment for the industry. Company Summaries - New Hope reported sales of 1.3378 million pigs in August 2025, a month-on-month increase of 2.71% and a year-on-year increase of 4.72%. However, revenue fell to 1.722 billion yuan, a month-on-month decrease of 4.45% and a year-on-year decrease of 30.73%, primarily due to a significant drop in selling prices, which averaged 13.54 yuan/kg, down 6.23% month-on-month and 32.74% year-on-year [1] - Dongrui Co. announced sales of 94,800 pigs in August 2025, with revenue of 160 million yuan, reflecting a month-on-month decline of 5.48%. The average selling price was 15.86 yuan/kg, down 2.02% month-on-month [1] - Wen's Co. reported sales of 3.2457 million pigs in August 2025, generating revenue of 4.825 billion yuan. The average selling price for live pigs was 13.90 yuan/kg, with year-on-year changes of 37.88% in sales volume but a decline of 17.70% in price [2] - Zhenghong Technology sold 16,800 pigs in August 2025, with revenue of 22.8655 million yuan, showing a month-on-month increase in volume of 3.46% but a revenue decrease of 12.12%. Year-on-year, sales volume increased by 63.31% and revenue by 21.14% [3] - Tianyu Bio sold 26,000 pigs in August 2025, with revenue of 29.8423 million yuan, reflecting a month-on-month increase of 50.83% in volume and 41.89% in revenue, but a year-on-year revenue decline of 53.32% [3] Industry Insights - The average price of pork in China's wholesale markets was 19.94 yuan/kg on August 29, 2025, down from 20.10 yuan/kg the previous week, indicating a continuous decline in pig prices for eight consecutive weeks [3] - Guotai Junan Futures noted that the increase in planned slaughter volumes by large groups and limited demand from smallholders has led to a supply pressure that is difficult to alleviate, with daily transactions falling short of expectations [3] - Guoxin Futures projected that the theoretical slaughter volume will continue to increase in September, with a significant rise expected in October, suggesting that supply growth will outpace seasonal consumption increases [4]

Group 1 - Huaneng Power announced that its shareholder Hunan Energy Group plans to reduce its stake by up to 20.31 million shares, not exceeding 1% of the total share capital [1] - Ankai Bus reported a production of 1,012 buses in August, a year-on-year increase of 68.06%, with sales of 773 buses, up 46.95% year-on-year [1] - Lianhuan Pharmaceutical received a drug registration certificate for Famotidine injection, classified as a Class 3 chemical drug [1][2] Group 2 - Dongrui Co. reported sales of 94,800 pigs in August, generating revenue of 160 million yuan, a month-on-month decrease of 5.48% [3] - Tiancheng Control's subsidiary received a notification for a passenger car seat assembly project, expected to start production in April 2026 [5] - ST Huluwa obtained a drug registration certificate for Cefodizime capsules, a third-generation broad-spectrum cephalosporin [6] Group 3 - Jiulong Biotech announced the resignation of its Vice Chairman and General Manager Liang Hongjun due to work adjustments [8] - Guanhua High-tech's shareholder plans to reduce its stake by up to 17.50 million shares, not exceeding 1% of the total share capital [9] - Hebei Steel received approval to issue bonds totaling up to 10 billion yuan [10] Group 4 - Yunnan Energy Investment's subsidiaries received a total of 309 million yuan in renewable energy price subsidies [12] - Zhenghong Technology reported sales of 16,800 pigs in August, with a revenue of 22.87 million yuan, showing a year-on-year increase in sales volume of 63.31% [14] - Jilin Aodong's subsidiary received a drug registration certificate for a solution used in asthma treatment [16] Group 5 - Aonong Biological reported a 26.84% year-on-year increase in pig sales volume in August, reaching 150,100 pigs [18] - Xingdesheng announced a share repurchase plan with a budget of 15 to 30 million yuan [20] - Yueyang Lin Paper's Chairman Ye Meng resigned due to work adjustments [22] Group 6 - Kangchen Pharmaceutical's controlling shareholder plans to reduce its stake by up to 4.78 million shares, not exceeding 3% of the total share capital [23] - Changchun Yidong's General Manager Liu Xiaodong resigned due to work adjustments [25] - Zhongzai Resources' subsidiary received a government subsidy of 12.75 million yuan [26] Group 7 - Tianyu Biological reported a 41.89% month-on-month increase in sales revenue from pig sales in August [27] - Changfei Optical's shareholder Draka Comteq B.V. reduced its stake from 10% to 5% [27] - Zhongchuan Technology's Chairman Wu Xingwang resigned due to work adjustments [28] Group 8 - Huakang Clean announced a successful bid for a medical service construction project valued at 131 million yuan [29] - Yuegui Co. plans to establish a wholly-owned subsidiary with a registered capital of 100 million yuan [31] - Baisheng Intelligent's Vice General Manager and Board Secretary Huang Lijun resigned for personal reasons [32] Group 9 - Jiangsu Shuntian will change its stock name to "Suhao Fashion" starting September 10, 2025 [34] - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.3759 million shares, not exceeding 1% of the total share capital [35] - Heng Rui Pharmaceutical received approval for clinical trials of HRS-4729 injection [37] Group 10 - Changfei Optical's shareholder plans to reduce its stake by up to 110,000 shares, not exceeding 0.15% of the total share capital [39] - Yutong Bus reported sales of 4,260 vehicles in August, a year-on-year increase of 16.78% [40] - JinkoSolar received 646 million yuan in renewable energy subsidies in August, a 248% increase year-on-year [41] Group 11 - Beijing Lier signed a strategic cooperation agreement with SenseTime and Xiwang Technology for AI collaboration [43] - Gongdong Medical's controlling shareholder plans to reduce its stake by up to 3% [44] - Zhonghuan Hailu terminated its control change plan and resumed trading [46] Group 12 - Longzi Co. reported a tax payment of 22.27 million yuan due to a tax audit [48] - Guoguang Chain's controlling shareholder plans to reduce its stake by up to 2.99% [49] - Guoxin Technology successfully tested a new high-performance chip for automotive electronics [50] Group 13 - GF Securities reported a cumulative increase in borrowings exceeding 20% of its net assets [51] - China Construction Bank's subsidiary plans to increase capital by 3 billion yuan [52] - Jifeng Technology plans to establish a wholly-owned subsidiary with a capital of 50 million yuan [53] Group 14 - Jiantou Energy received approval for a stock issuance plan to specific investors [54] - Shanghai Laishi's executives plan to collectively increase their holdings by at least 6 million yuan [55] - Wencan Co. reported a fire incident at its subsidiary, with no casualties reported [56]

证券代码：603717 证券简称：天域生物 公告编号：2025-077 天域生物科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 天域生物科技股份有限公司（以下简称"公司"）现将 2025 年 8 月养殖业务 主要经营数据公告如下： 一、2025 年 8 月养殖行业主要经营数据 别为 50.83%、41.89%，同比变动分别为 2.04%、-53.32%。 收入 36,240.60 万元，同比下降 0.05%。 月度主要经营数据汇总如下： 销售数量（万头） 销售收入（万元） 期末库存量 月份 当月 累计 当月 累计 （万头） 注：因四舍五入，以上数据可能存在尾差。 二、特别提示 因此仅作为阶段性数据供投资者参考。 司生猪销售数量和销售收入存在月度波动风险，敬请广大投资者注意投资风险。 特此公告。 天域生物科技股份有限公司董事会 ...